Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

作者： Robert S. McNeill1, Ralf S. Schmid2, Ryan E. Bash3, Mark Vitucci4, Kristen K. White1, Andrea M. Werneke3, Brian H. Constance5, Byron Huff6, C. Ryan Miller2,3,7 1Department of Pathology and Laboratory Medicine,University of North Carolina School of Medicine, 2Lineberger Comprehensive Cancer Center,University of North Carolina School of Medicine, 3Division of Neuropathology, Department of Pathology and Laboratory Medicine,University of North Carolina School of Medicine, 4Curriculum in Genetics and Molecular Biology,University of North Carolina School of Medicine, 5Biological and Biomedical Sciences Program,University of North Carolina School of Medicine, 6Department of Radiation Oncology,Emory University School of Medicine, 7Department of Neurology, Neurosciences Center,University of North Carolina School of Medicine

简介：

Overview

This study focuses on generating genetically engineered astrocytoma models from wild-type astrocytes and neural stem cells harvested from conditional genetically engineered mice. The models are characterized in vitro and in vivo to understand the phenotypic consequences of astrocytoma-associated mutations.

Key Study Components

Area of Science

• Neuro-oncology
• Cell biology
• Genetic engineering

Background

• Astrocytomas are a type of brain tumor arising from astrocytes.
• Understanding the genetic basis of astrocytoma can inform treatment strategies.
• Conditional genetic engineering allows for targeted studies of specific mutations.
• Modeling astrocytoma in vitro and in vivo is crucial for phenotypic characterization.

Purpose of Study

• To generate astrocytoma models for phenotypic characterization.
• To investigate the impact of specific mutations on glioagenesis.
• To answer key questions in neuro-oncology regarding astrocytoma mutations.

Methods Used

• Harvesting wild-type primary cells from genetically engineered mice.
• Infection of primary cells with an adenoviral vector for genetic recombination.
• Serial culture of recombined cells for phenotypic analysis.
• Characterization of tumorogenic relevant phenotypes in vitro and in vivo.

Main Results

• Successful generation of astrocytoma models from defined cell types.
• Characterization of phenotypic changes associated with mutations.
• Insights into the role of specific mutations in astrocytoma development.
• Potential implications for understanding and treating astrocytomas.

Conclusions

• The study provides a framework for modeling astrocytoma pathogenesis.
• Findings contribute to the understanding of astrocytoma-associated mutations.
• Future research can build on these models to explore therapeutic options.

Frequently Asked Questions